ESR1 and breast carcinoma: Along with the detection of MDM2-C in ER+ breast cancer cell lines, Okoro et al. found increased MDM2-C expression in Burkitt Lymphoma cells (MANCA) and an osteosarcoma cell line (SJSA-1) [17].